eClinical Solutions Market Worth $15.7 Billion By 2027

The global eClinical solutions market size is expected to reach USD 15.7 billion by 2027, according to a new report by Grand View Research, Inc., progressing at a CAGR of 13.8% during the forecast period. Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel the demand for eClinical solutions.

Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years. As the demand for tracking and analyzing clinical data increases, the need for effective clinical solutions rises. Unmet needs to manage efficient clinical development process are poised to boost the market over the forecast period.

Moreover, digital transformation in the field of clinical trials and preference for data centric approach are providing a tremendous push to the market. Demand for integrated clinical IT solutions is increasing due to massive volume of data generated during clinical development processes. eClinical solutions offer a single source of information that helps optimize the cost by eliminating redundant data entry and reducing on-site verification and source data verification. Rising awareness regarding these advantages is projected to propel the market.

Adoption of eClinical workflows in trials offers enormous potential in clinical development processes. These solutions can facilitate decision making in every stage of the development process. They also help reduce cost and time between development phases by utilizing seamless designs and by identifying failing compounds. In addition, it offers rapid access to data and patient safety information, which is helpful in making quick decisions.

Market players engage in new product development and strategic alliances, including partnership agreements, promotional activities, and acquisitions, to keep market rivalry high. For instance, in October 2017, Oracle entered into a collaboration with Healthx Inc. to provide SaaS solutions to healthcare payers for core administration and digital engagement.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the study suggest:

CTMS led the eClinical solutions market by product in 2019 owing to benefits such as centralized end-to-end management of clinical trial activities, elimination of reliance on manual processes, real-time status tracking, and maintenance of multiple databases, which cumulatively improve the overall efficiency of clinical trials
By delivery mode, cloud-based systems are anticipated to exhibit the highest CAGR during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup. Real-time data is available through these systems, which enables users to take quick decisions and provide high-quality information for risk-based monitoring
CROs held the largest share in the market in 2019 on the basis of end use. The segment is projected to expand at a remarkable pace during the forecast period owing to growing inclination of pharmaceutical companies to reduce overall expenditure
Key players operating in the market include DATATRAK International, Inc.; IBM Watson Health; Medidata Solutions Inc.; Oracle Corporation; BioClinica; PAREXEL International Corporation; CRF Health; OmniComm Systems Inc.; and ERT. Most companies engage in various business strategies such as mergers and acquisitions and new product development to gain greater market share.

Portable Medical Devices Market Size Worth $85.3 Billion By 2025

The global portable medical devices market size is expected to reach USD 85.3 billion by 2025. It is anticipated to expand at a CAGR 8.7% over the forecast period, according to a new report by Grand View Research, Inc. The market is majorly driven by the increasing adoption of portable therapeutics, diagnostics, and monitoring devices in healthcare facilities. Growing usage of small, lightweight, and handheld devices such as spirometers that help in diagnosing the respiratory diseases is anticipated to provide significant traction to the global market in the forthcoming years.

Furthermore, the upward trend of preventive healthcare and subsequently rising adoption of smart wearables are among other factors boosting the growth of the market for portable medical devices. Fitness trackers and smartwatches exhibit features that offer healthcare benefits. Wearables compute data from day to day activities of users. This data can be used by the physicians to decide a treatment plan.

The rising geriatric population coupled with high prevalence of chronic diseases is also projected to boost the market. Rising adoption of portable devices such as cardiac monitoring, respiratory monitoring, and image-guided therapy systems for the management of chronic conditions such as diabetes, cardiovascular diseases, and respiratory diseases is anticipated to bode well for market growth in the near future. According to the American Cancer Society (ACS) estimates from 2012, the global incidence of cancer is expected to reach nearly 21.7 million by 2030. This is anticipated to drive demand for advanced imaging and therapeutic technologies, which, in turn, is expected to drive the portable medical devices market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/portable-medical-devices-market

Further key findings from the report suggest:

In 2017, monitoring devices held the largest market share in terms of revenue owing to increasing adoption of monitoring systems by hospitals, clinics, and other healthcare facilities for better disease management
Smart wearable devices segment is expected to expand at the fastest CAGR 19.0%over the forecast period owing to a rising focus on preventive healthcare
Other applications held the largest market share in 2017. Gynecology segment is anticipated to expand at the fastest CAGR over the forecast period
North America accounted for the largest revenue share of 41.7% in 2017 owing to the high adoption of technologically advanced devices and high treatment rates. However, Asia Pacific is expected to register the fastest CAGR over the forecast period
Key players in the portable medical devices market include General Electric Company, OMNOR Corporation, VYAIRE, SAMSUNG, Koninklijke Philips N.V., Medtronic, F.Hoffmann-La Roche Ltd, and Nox Medical

RFID in Healthcare Market Worth $10.65 Billion By 2025

The global rfid in healthcare market size is expected to reach USD 10.65 Billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 22.4% during the forecast period. Some of the key contributors to the growth include rising focus on reducing operational costs and streamline the workflow, demand for efficient supply chain management, and need to improve the quality and efficiency of care.

High operational costs associated with the healthcare industry is expected to boost the adoption of RFID technology in healthcare organizations. Pharmaceutical companies, medical device manufacturers, hospitals, and various other healthcare organizations integrate this technology to control inventory costs. RFID technology enables these organizations in efficient inventory management and help avoid stock out and overstock situations. RFID tags enable the surgical staff in easy tracking of medical devices used in operation theatres, thereby improving patient safety. Growing requirement for reduction in operating costs is expected to drive the increase in adoption of RFID. This technology is also used in laboratories, blood banks, and pathology labs for efficient product tracking and better workflow management.

The use of RFID technology enables better communication, adequate patient monitoring, patient identification, and patient tracking. This method aids in decreasing medication errors and increases safety. The rising need for patient monitoring and mandates for increasing safety are also contributing to the growth. Patient tracking across different hospital sections using this technology helps reduce waiting times and is thus gaining significance in hospitals.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/rfid-in-healthcare-market

Further key findings from the report suggest:

RFID tags product segment held majority of the market share in 2018 due to rising awareness regarding the benefits of these devices
Increasing use of tags for tracking various assets, patients, staff, pharmaceuticals, and donated blood is expected to boost the market during the forecast period
Pharmaceutical tracking application segment held the largest market share in 2018, owing to rising needs to identify counterfeit drugs and demand for inventory management
North America led the global market owing to increasing number of hospitals and presence of regulations on patient safety
Asia Pacific is anticipated to witness the fastest CAGR owing to the presence of a large pharmaceutical industry requiring this technology for process streamlining
Some of the key players operating in the RFID in healthcare market include LogiTag, CenTrak, SpaceCode, Impinj, Zebra Technologies Corporation, Biolog-id, Terso Solutions, Carinal Health, Mobile Aspects, Tagsys RFID, Pepperl+Fuchs, and metraTec GmbH

Healthcare IT Market Size Worth $147.3 Billion By 2027

The global healthcare IT market size is expected to reach USD 147.3 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.3% from 2020 to 2027. Increasing prevalence of chronic diseases, growing inclination towards automating, and depending on computationally prepared information to facilitate patients’ database and maintaining a single point of access is driving the demand for healthcare IT solutions. This, in turn, is significantly contributing to market growth.

Moreover, initiatives taken by public and private organizations to transform the existing healthcare infrastructure by providing more advanced healthcare IT solutions are anticipated to drive the market during the forecast period. In June 2020, GE Healthcare launched Thoracic Care Suite to detect chest X-Ray abnormalities such as pneumonia and tuberculosis caused by COVID-19 as well as to support clinicians and health systems to ensure quick diagnosis and effective treatment for patients.

In 2019, North America dominated the market owing to increasing demand for quality healthcare, growing focus on patient safety and care, increasing implementation of tele-monitoring, tele-orientation, and tele-consultation services. In addition, rising awareness of EHRs is expected to drive the market in the region. On the other hand, Asia Pacific is anticipated to be the fastest growth during the forecast period owing to the increasing incidence of chronic diseases, growing geriatric population, government initiatives to support the adoption of technology-driven tolls, and the increasing prevalence of COVID-19 in the region. For instance, in June 2020, the government launched the Make in India’s healthcare sector plans to develop healthier societies and support newer models of telemedicine.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-it-market

Further key findings from the report suggest:

The growth of the healthcare IT market is owing to rising geriatric population and growing demand for preventive healthcare services
The Electronic Health Records (EHRs) segment dominated the market in 2019, owing to increasing implementation of EHRs in healthcare facilities
North America dominated the market in 2019 owing to improved healthcare infrastructure and the rising prevalence of chronic diseases in the region.

Liposuction Surgery Devices Market Size Worth $1.2 Billion By 2026

The global liposuction surgery devices market size is expected to reach USD 1.2 billion by 2026 at a CAGR of 11.7%, according to a new report by Grand View Research, Inc. Increased awareness regarding new cosmetic treatments in the developed economies, such as North America is one of the major driving factors of the liposuction surgery devices. In addition, integration of modern technology and adoption of technologically advanced surgical devices is fueling market growth.

The growing demand for cosmetic surgeries across the globe is another driving factor of this market. Lipoplasty is one of the common cosmetic surgeries witnessed in the United States. Annually, more than 3,00,000 liposuction surgeries are operated with an approximate cost of $2000-3500. High disposable income of consumers is another driving factor for the growth of liposuction surgery in North America. These factors are expected to propel the industry growth.

Suction-assisted lipectomy, power-assisted, ultrasound-assisted, laser-assisted, and RF-assisted are some of the current technologies used in surgeries. Different technologies are used based on the patient’s body characteristics and cosmetic surgeon’s preference. The right use of technology will bring a better outcome to the lipoplasty surgery.

In addition, the rising obesity cases are increasing the demand for liposuction surgery. However, minor complications, such as numbness, swelling, bad bruising, and more associated with targeted surgery is hampering market growth. Nonetheless, increasing research and development in the domain and launch of new technologies are expected to overcome these drawbacks.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/liposuction-surgery-devices-market

The standalone segment accounted held a dominant share of the liposuction surgery devices market in 2018 in terms of revenue. Easy usage, convenience, and growing innovations in the devices are expected to propel the segment growth in the coming years
Growing number of qualified & trained cosmetic surgeons, and practitioners are encouraging patients to opt for such cosmetic surgeries.
Laser-assisted liposuction (LAL) segment held a significant share of the market due to the increasing adoption owing to its benefits, such as a quick and effective way of removing body fat.
Key players of the market include Solta Medical, Cynosure Inc., Sciton Inc., Wells Johnson Co, Invasix Ltd, Zeltiq aesthetics Inc, Alma Lasers, Bausch Health, Genesis Biosystems, Inc., Hologic Inc., and YOLO Medical Inc.

Nuclear Medicine Market Size Worth $12.6 Billion By 2027

The global nuclear medicine market size is expected to reach USD 12.6 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Research and development of advanced technologies by the key players for diagnosis and treatment of diseases is expected to drive the radiopharmaceuticals market.

For instance, in May 2019, GE Healthcare with Indi Molecular, Inc., collaborated to develop Protein Catalyzed Capture (PCC) technology and immune cell-targeted PET tracer candidates. This diagnostic tool will help in better understanding of patient’s immune cell and in early treatment response.

Rising prevalence of cancer and cardiovascular diseases is one of the major factors responsible for market growth. Moreover, high prevalence of cancer in emerging Asian countries is creating huge demand for radiopharmaceuticals in diagnosing the disease. For instance, according to the GLOBOCAN, in 2018, approximately 48.4% of cancer cases were registered in Asia.

In addition, presence of standard guidelines prepared by regulatory authorities for radiopharmaceuticals is expected to accelerate market growth. For instance, in August 2019, FDA published a guideline for non-clinical studies and product labelling that are not covered by FDA and ICH guidelines for radiopharmaceuticals used in the treatment of cancer.

Manufacturers are focusing on development of innovative technologies to produce medical isotopes that can fulfill the increasing demand for nuclear medicines. For instance, in October 2018, with the support of ASML, The Institute For Radioelements (IRE) developed and built an electron beamline to manufacture medical isotope molybdenum 99 (Mo-99). Due to this innovative technology, the process of production is waste-free and non-fission.

In addition, research centers and hospitals are launching novel nuclear medicine techniques to treat various diseases at an affordable cost as compared to the existing treatments. For instance, in August 2017, the Kovai Medical Centre and Hospital (KMCH) had launched Rhenium 188 Lipiodol to treat liver cancer and other diseases such as metastatic bone pain, rheumatoid arthritis, and hemophilic bleeding joints at low cost with lesser hospitalization.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market

Further key findings from the study suggest:

In 2019, the SPECT segment had dominated the market owing to integration of SPECT with X-ray/CT that has gained more acceptance and proved to be useful in many clinical situations due to its high accuracy
PET diagnostic nuclear medicine is expected to witness the fastest growth over the forecast period owing to the increasing adoption of high resolution PET scanners
In case of the therapeutic segment, brachytherapy is anticipated to be the fastest growing segment due to the higher radiation protection as compared to other treatment options
The oncology application segment dominated the nuclear medicine market in 2019 owing to the presence of pipeline drugs and high prevalence of cancer
The market in Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and development of radiopharmaceuticals for diagnosis and treatment of various diseases
Key players in the market include companies such as Eckert and Ziegler Group Nordion, Inc.; Bracco Imaging S.p.A.; and GE Healthcare as well as government organizations such as Department of Atomic Energy and Australian Nuclear Science and Technology Organization (ANSTO).

Control Valves Market Size Worth $11.85 Billion By 2025

The global control valves market size is expected to reach USD 11.85 billion by 2025, according to a study conducted by Grand View Research, Inc., rising at a CAGR of 6.50% during the forecast period. Surging demand from industrial sectors such as energy & power, water & wastewater treatment, and oil & gas industry and growing adoption of industrial automation propelling the smart control valves market are fueling the demand for control valves. Additionally, rising demand for control valves in the pharmaceutical and food & beverages industries is expected to drive the market.

Increasing adoption of control valves is rising continuously owing to the benefits they offer in controlling temperature and pressure throughout the downstream, midstream, and upstream activities. Therefore, growing oil & gas exploration activities are triggering the demand for control valves. Control valves offer various benefits of installing modernized and sophisticated fluid handling systems. In the pharmaceutical industry, there is a rising demand for fluid handling systems, owing to safety procedures in order to manufacture a hygienic and safe product.

These sophisticated fluid handling mechanisms are helpful in speeding up the manufacturing process, thus ensuring optimal performance. Moreover, the food & beverages industry utilizes control valves to speed up the manufacturing process and ensure the hygiene of end products such as packaged food. Surging demand for packaged food is augmenting the control valves market growth. This is due to the application of flow control devices with suitable control valve design and technology for improved quality of end product.

Asia Pacific is expected to dominate the market owing to increasing demand from the energy & power and water & wastewater industries. These industries are investing heavily to automate their flow-control processes, so as to increase production efficiency and simultaneously reduce error ratio. Furthermore, expanding the production of oil sands and shale gas in North America and rising oil & gas exploration activities in regions such as Middle East and Africa, and Asia Pacific are accelerating the demand for control valves over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/control-valves-market

Further key findings from the study suggest:

The actuator segment is expected to dominate the control valves market throughout the forecast period owing to significant cost as compared to valve body and other components
The market for control valves with size ranging from 1” to 6” is expected to dominate throughout the forecast period owing to its wide demand across the food & beverages, pharmaceutical, energy & power, and chemical industries.
Asia Pacific is expected to be the most prominent region over the forecast period owing to increasing demand from industries such as oil & gas, water & wastewater, and energy & power in emerging economies such as China and India.
Prominent industry participants include Emerson Electric Co., Flowserve Corporation, IMI plc, Schlumberger Limited, and AVK Holding A/S.

Healthcare Cloud Computing Market Size Worth $27.8 Billion By 2026

The global healthcare cloud computing market size is expected to reach USD 27.8 billion by 2026, according to a new report by Grand View Research, exhibiting a CAGR of 11.8% over the forecast period. The associated benefits of data analytics and increase in demand for flexible & scalable data storage by healthcare professionals is expected to drive the demand for these services over the forecast period.

Healthcare organizations are digitalizing their IT infrastructure and deploying cloud servers to improve features of systems. These solutions help organizations in reducing infrastructure cost & interoperability issues and aid in complying with regulatory standards. Hence, rising demand from health professionals to curb IT infrastructure costs and limit space usage are anticipated to boost market growth over the forecast period.

Increase in government initiatives undertaken to develop and deploy IT systems in this industry is one of the key drivers of this market. Moreover, increase in partnerships between private & public players and presence of a large number of players offering customized solutions are some of the factors anticipated to drive demand in the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-cloud-computing-market

Further key findings from the report suggest:

Non-clinical information systems such as revenue cycle management, health information exchange, financial management, etc., accounted for the largest revenue share in application segment in 2018
Financial management segment held 23.0% share of the non-clinical segment in 2018 while billing and accounts management is expected to grow at the considerable CAGR during the forecast period
Private deployment model dominated the overall market owing to its benefits and ease of usage
Software as a Service (SaaS) model accounted for the largest revenue share as of 2018 as it is widely accepted. This model enables access to applications on a cloud from various devices
Pay-as-you-go pricing model is anticipated to gain popularity in the coming years, as the consumer only pays for services being used
North America dominated the market with a share of over 55.0% in 2018. This can be attributed to an increase in demand from payers as well as providers
Some key players of this healthcare cloud computing market include Athenahealth, Cerner Corporation, CareCloud Corporation, Carestream Corporation, Epic Systems Corporation, Dell Inc., and Sectra AB
Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected to aid market growth in the coming years.

Healthcare Business Intelligence Market Worth $10.64 Billion By 2025

The global healthcare business intelligence market size is expected to reach USD 10.64 billion by 2025, registering a CAGR of 12.8% during the forecast period, according to a new report by Grand View Research, Inc. Increase in adoption of data-driven decision making, emergence of cloud based business intelligence (BI) solutions for healthcare industry, increased focus to reduce spending, and emergence of mobile-based healthcare BI solutions are the key factors contributing to the growth. Growing requirement of business intelligence tools to reduce costs for operational performance, claims, and clinical analysis is another major factor positively impacting the market.

Factors, such as the constantly increasing volume of digital information and data sources, complexity of data generated in healthcare organizations, coupled with growing need for the advanced business intelligence solutions to support decision-making are boosting the demand for business intelligence solutions and services. The massive amounts of unstructured and structured data generated by medical organizations and institutions is critical to manage, thus there is huge requirement for advanced healthcare BI software by hospitals and other healthcare organizations.

In order to gain insights about patient care and satisfaction, clinical operations, labor distribution, physician practices, and administration and management; hospitals and other healthcare facilities require data visualization and predictive modeling tools, which in turn is increasing demand for healthcare business intelligence software among these end users.

Increasing adoption of cloud-based healthcare BI software solutions coupled with high dependency of healthcare on digital technology to operate functions of a complex healthcare system is further boosting the adoption of BI software over the past years. For instance, KenSci Clinical Analytics, a platform designed by Microsoft to predict clinical and operational risk involved in a healthcare facility to improve health outcomes and reduce operational costs.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-business-intelligence-market

Further key findings from the study suggest:

Software emerged as the largest product segment with a revenue share of 68.4% in 2018
Cloud-based mode of delivery accounted for the largest revenue share in 2018 and is expected to register the fastest CAGR over the forecast period
Healthcare payers emerged as the leading end use segment, however healthcare providers end use segment is expected to grow at a significant CAGR over the forecast period
North America accounted for the largest share of the healthcare business intelligence market due to increased implementation of healthcare BI solutions and services by the providers to offer enhanced patient care and reduced healthcare expenses
Market players, such Oracle Corporation; SAP; Microsoft; Salesforce; Tableau Software; TIBCO Software Inc.; Sisense Inc.; and Looker Data Sciences, Inc. are focused on increasing collaboration with powerful analytics platform providers to gain competitive edge in the market

Blood Culture Test Market Worth $7.3 Billion by 2026

The global blood culture test market size is expected to reach USD 7.3 billion, at a CAGR of 9.1% by 2026, according to a new report by Grand View Research, Inc. Increasing prevalence of bloodstream infections and infectious diseases is the most significant factor anticipated to propel the growth. Rising demand for advanced diagnostic techniques for the diagnosis of infectious diseases, such as sepsis, is projected to drive the growth. Thus, many manufacturing companies have begun focusing on development of advanced diagnostic instruments and consumables. For instance, Cepheid offers Xpert MRSA/SA assay that aids in accurate detection of SA and MRSA in positive blood culture specimens in about an hour.

Introduction of various government initiatives pertaining to the prevention and control of infections is likely to propel the demand for blood culture tests. According to the Centers for Disease Control and Prevention (CDC), there was 46% decrease in central line-associated bloodstream infections in U.S. between 2008 and 2013, owing to the efforts taken by the U.S. government for the prevention of Hospital-acquired Infections (HAIs).

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-culture-tests-market

Further key findings from the report suggest:

Conventional blood culture technique was the largest revenue-grossing segment in 2018 owing to increased applications of this method in hospitals, independent clinical laboratories, and pathology laboratories
In product segment, consumables accounted for the largest market share in terms of revenue in 2018, due the product applications in diagnostics and research, with repetitive purchase, such as blood culture media, assay, kits, and reagents, adding to the revenue
Automated blood culture systems is the fastest growing segment owing to the advantages of automation, such as low chances of error and faster result generation
Molecular technology is projected to expand at the highest CAGR over the forecast period, due to rising demand for advanced products by hospitals and laboratories for diagnosis of infectious diseases
Bacterial infections accounted for the largest revenue share in 2018, due to the fact that they are the most common cause for infection in the blood
Reference laboratories is projected to expand at the highest CAGR during the study period, because there is an increase in outsourcing of blood tests by hospitals to reference laboratories
North America accounted for the largest revenue share of the blood culture test market in 2018, due to the presence of well-developed healthcare infrastructure in this region
Asia Pacific is anticipated to register the highest CAGR during the forecast period owing to increased focus of government on the prevention of infectious diseases
Few key players include Becton, Dickinson and Company; bioMérieux SA; Thermo Fisher Scientific, Inc.; Danaher Corporation; Luminex Corporation; Roche; Bruker Corporation; and Abbott Laboratories.